Welcome to our dedicated page for BHAV Acquisition news (Ticker: BHAVU), a resource for investors and traders seeking the latest updates and insights on BHAV Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BHAV Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BHAV Acquisition's position in the market.
BHAV Acquisition Corp (Nasdaq: BHAVU) closed a $100.0 million initial public offering on March 20, 2026, selling 10,000,000 units at $10.00 per unit. Each unit includes one Class A share and one right, with $10.00 per unit deposited into a trust account.
The units began trading on Nasdaq under BHAVU on March 19, 2026; separate trading of Class A shares and rights is expected under BHAV and BHAVR. The company granted a 45-day option for 1,500,000 additional units and intends to use net proceeds to pursue a business combination. Maxim Group acted as sole book-running manager; Form S-1 was declared effective March 18, 2026.
BHAV Acquisition Corp (Nasdaq: BHAVU) priced an initial public offering of 10,000,000 units at $10.00 per unit, implying $100.0 million gross proceeds with $10.00 per unit deposited into a trust account.
Each unit contains one Class A ordinary share and one right (each right equals 1/4 of one Class A share). Units begin trading March 19, 2026; offering expected to close March 20, 2026. Maxim Group is sole book-runner; underwriter has a 45-day option to buy up to 1,500,000 additional units.